ABBV AbbVie Inc

USD 171.73 +3.97 ( +2.37)%
Icon

AbbVie Inc (ABBV) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 171.73

+3.97 (+2.37)%

USD 294.35B

6.85M

USD 204.41(+19.03%)

USD 156.00 (-9.16%)

Icon

ABBV

AbbVie Inc (USD)
COMMON STOCK | NYE
USD 171.73
+3.97 ( +2.37)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 294.35B

USD 156.00 (-9.16%)

USD 171.73

AbbVie Inc (ABBV) Stock Forecast

Show ratings and price targets of :
USD 204.41
(+19.03%)

Based on the AbbVie Inc stock forecast from 17 analysts, the average analyst target price for AbbVie Inc is USD 204.41 over the next 12 months. AbbVie Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AbbVie Inc is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, AbbVie Inc’s stock price was USD 171.73. AbbVie Inc’s stock price has changed by +1.24% over the past week, -7.94% over the past month and +23.79% over the last year.

No recent analyst target price found for AbbVie Inc
No recent average analyst rating found for AbbVie Inc

Company Overview AbbVie Inc

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Cro...Read More

https://www.abbvie.com

1 North Waukegan Road, North Chicago, IL, United States, 60064-6400

50,000

December

USD

United States

Adjusted Closing Price for AbbVie Inc (ABBV)

Loading...

Unadjusted Closing Price for AbbVie Inc (ABBV)

Loading...

Share Trading Volume for AbbVie Inc Shares

Loading...

Compare Performance of AbbVie Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ABBV

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To AbbVie Inc (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LLY
Eli Lilly and Company -3.49 (-0.46%) USD737.03B 86.94 63.35

Frequently Asked Questions About AbbVie Inc (ABBV) Stock

Based on ratings from 17 analysts AbbVie Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 27 buy, sell and 5 hold ratings.

ABBV stock's dividend yield is 3.94%. Our analysis grades ABBV stock's dividend yield at F. This means that ABBV stock's dividend yield is above 57% of the stocks in the Drug Manufacturers - General sector in the NYE exchange. Based on this ABBV may be a average dividend stock for its sector.

Based on targets from 17 analysts, the average taret price for ABBV is USD 204.41 over the next 12 months. The maximum analyst target price is USD 231 while the minimum anlayst target price is USD 172.

ABBV stock's Price/Earning ratio is 58.04. Our analysis grades ABBV stock's Price / Earning ratio at F. This means that ABBV stock's Price/Earning ratio is above 71% of the stocks in the Drug Manufacturers - General sector in the NYE exchange. Based on this ABBV may be a overvalued for its sector.

The last closing price of ABBV's stock was USD 171.73.

The most recent market capitalization for ABBV is USD 294.35B.

Based on targets from 17 analysts, the average taret price for ABBV is projected at USD 204.41 over the next 12 months. This means that ABBV's stock price may go up by +19.03% over the next 12 months.

We can't find any ETFs which contains AbbVie Inc's stock.

As per our most recent records AbbVie Inc has 50,000 Employees.

AbbVie Inc's registered address is 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400. You can get more information about it from AbbVie Inc's website at https://www.abbvie.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About AbbVie Inc (ABBV) Stock

Based on ratings from 17 analysts AbbVie Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 27 buy, sell and 5 hold ratings.

ABBV stock's dividend yield is 3.94%. Our analysis grades ABBV stock's dividend yield at F. This means that ABBV stock's dividend yield is above 57% of the stocks in the Drug Manufacturers - General sector in the NYE exchange. Based on this ABBV may be a average dividend stock for its sector.

Based on targets from 17 analysts, the average taret price for ABBV is USD 204.41 over the next 12 months. The maximum analyst target price is USD 231 while the minimum anlayst target price is USD 172.

ABBV stock's Price/Earning ratio is 58.04. Our analysis grades ABBV stock's Price / Earning ratio at F. This means that ABBV stock's Price/Earning ratio is above 71% of the stocks in the Drug Manufacturers - General sector in the NYE exchange. Based on this ABBV may be a overvalued for its sector.

The last closing price of ABBV's stock was USD 171.73.

The most recent market capitalization for ABBV is USD 294.35B.

Based on targets from 17 analysts, the average taret price for ABBV is projected at USD 204.41 over the next 12 months. This means that ABBV's stock price may go up by +19.03% over the next 12 months.

We can't find any ETFs which contains AbbVie Inc's stock.

As per our most recent records AbbVie Inc has 50,000 Employees.

AbbVie Inc's registered address is 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400. You can get more information about it from AbbVie Inc's website at https://www.abbvie.com.
Loading...